… with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) …
EM Hylek, C Held, JH Alexander, RD Lopes… - Journal of the American …, 2014 - jacc.org
… major bleeding on the basis of the components of the major bleeding definition, to explore
major bleeding by location, to define 30-day mortality after a major bleeding event, and to …
major bleeding by location, to define 30-day mortality after a major bleeding event, and to …
Major bleeding risk among non‐valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real‐world” observational study in the …
GYH Lip, X Pan, S Kamble, H Kawabata… - … journal of clinical …, 2016 - Wiley Online Library
… We defined first major bleeding on an anticoagulant as a major critical site bleeding in an
inpatient or outpatient setting, occurring anytime during the period of drug use or within 30 …
inpatient or outpatient setting, occurring anytime during the period of drug use or within 30 …
Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy: results from a Nationwide Danish Cohort Study
N van Rein, U Heide-Jørgensen, WM Lijfering… - Circulation, 2019 - Am Heart Assoc
… patients with atrial fibrillation on vitamin K antagonist and direct oral anticoagulant triple
therapy experienced a high rate of major bleeding across all subgroups. Bleeding rates were …
therapy experienced a high rate of major bleeding across all subgroups. Bleeding rates were …
Stroke and major bleeding risk in elderly patients aged≥ 75 years with atrial fibrillation: the Loire Valley atrial fibrillation project
… document, 10 we defined major bleeding using the BARC bleeding definition as follows: …
vision, overt bleeding plus hemoglobin drop >5 g/dL, tamponade, bleeding requiring surgical or …
vision, overt bleeding plus hemoglobin drop >5 g/dL, tamponade, bleeding requiring surgical or …
Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies
NS Roskell, M Samuel, H Noack, BU Monz - Europace, 2013 - academic.oup.com
… major bleeding, which was consistent across most trials (Table 1). The most frequent definition
for major bleeding was bleeding that was fatal or overt bleeding … of major bleeding in the …
for major bleeding was bleeding that was fatal or overt bleeding … of major bleeding in the …
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin
EM Hylek, C Held, JH Alexander, RD Lopes… - Journal of the American …, 2014 - infona.pl
… major bleeding on the basis of the components of the major bleeding definition, to explore
major bleeding by location, to define 30-day mortality after a major bleeding event, and to …
major bleeding by location, to define 30-day mortality after a major bleeding event, and to …
Predicting major bleeding in ischemic stroke patients with atrial fibrillation
NA Hilkens, A Algra, JP Greving - Stroke, 2017 - Am Heart Assoc
… scores for major bleeding in patients with atrial fibrillation and a … for major bleeding in
patients with atrial fibrillation treated with … of oral anticoagulants among bleeding risk categories. …
patients with atrial fibrillation treated with … of oral anticoagulants among bleeding risk categories. …
Bleeding risk assessment and management in atrial fibrillation patients
GYH Lip, F Andreotti, L Fauchier… - Thrombosis and …, 2011 - thieme-connect.com
… a consensus on bleeding risk assessments in atrial fibrillation (… best practice’ in dealing with
bleeding risk in AF patients when … major bleeding events into clinically relevant major bleeds …
bleeding risk in AF patients when … major bleeding events into clinically relevant major bleeds …
Major bleeding complications and persistence with oral anticoagulation in non‐valvular atrial fibrillation: contemporary findings in real‐life Danish patients
M Lamberts, L Staerk, JB Olesen… - Journal of the …, 2017 - Am Heart Assoc
… warfarin as stroke prophylaxis in atrial fibrillation, but data on real‐life patient experience,
including bleeding risk, are lacking. Our objective was to compare major bleeding events and …
including bleeding risk, are lacking. Our objective was to compare major bleeding events and …
Risk of bleeding with dabigatran in atrial fibrillation
I Hernandez, SH Baik, A Piñera… - JAMA internal medicine, 2015 - jamanetwork.com
… We found that dabigatran was associated with a higher incidence of major bleeding, a higher
risk of gastrointestinal bleeding, but a lower risk of intracranial hemorrhage than warfarin. …
risk of gastrointestinal bleeding, but a lower risk of intracranial hemorrhage than warfarin. …
相关搜索
- atrial fibrillation major bleeding in patients
- nonvalvular atrial fibrillation major bleeding risk
- atrial fibrillation major bleeding complications
- atrial fibrillation cohort study
- atrial fibrillation apixaban for reduction
- atrial fibrillation risk factors
- atrial fibrillation ischemic stroke
- bleeding risk non-valvular atrial fibrillation
- loire valley atrial fibrillation project
- atrial fibrillation other thromboembolic events
- atrial fibrillation apixaban or warfarin
- atrial fibrillation oral anticoagulation
- atrial fibrillation aristotle trial
- major bleeding vitamin k antagonists
- atrial fibrillation patients
- fibrillation patients major bleeding risk